Key terms
About BIO
Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, and test kits. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest BIO news
Apr 11
5:31pm ET
OncoCyte, BioRad to partner on global launch of GraftAssure assay
Apr 10
4:15pm ET
Bio-Rad COO Andrew Last to retire
Apr 08
9:46pm ET
RBC Capital Reaffirms Their Buy Rating on Bio-Rad Laboratories (BIO)
Apr 03
9:54am ET
UPS upgraded, PepsiCo downgraded: Wall Street’s top analyst calls
Apr 03
5:56am ET
Bio-Rad downgraded to Neutral on limited visibility at Citi
Apr 03
5:39am ET
Bio-Rad downgraded to Neutral from Buy at Citi
Mar 20
8:42am ET
Bio-Rad Laboratories Announces New CFO Roop K. Lakkaraju
Mar 20
8:41am ET
Bio-Rad appoints Roop Lakkaraju EVP, CFO
Mar 01
6:30am ET
Analysts Are Bullish on Top Healthcare Stocks: Argenx Se (ARGX), Bio-Rad Laboratories (BIO)
Feb 22
7:30am ET
Wall Street Analysts Are Bullish on Top Healthcare Picks
Feb 21
4:46pm ET
Bio-Rad Laboratories Reports Strong Sartorius AG Financials
Feb 16
9:55am ET
Early notable gainers among liquid option names on February 16th
Feb 16
8:40am ET
Analysts Have Conflicting Sentiments on These Healthcare Companies: Bio-Rad Laboratories (BIO), Ultragenyx Pharmaceutical (RARE) and West Pharmaceutical Services (WST)
Feb 16
7:38am ET
Bio-Rad Laboratories (BIO) Receives a Buy from RBC Capital
Feb 16
7:10am ET
Analysts Are Bullish on Top Healthcare Stocks: Corcept Therapeutics (CORT), Bio-Rad Laboratories (BIO)
Feb 15
4:23pm ET
Bio-Rad sees FY24 revenue up 1%-2.5%
Feb 15
4:20pm ET
Bio-Rad reports Q4 EPS $3.10, consensus $2.82
Feb 14
5:13pm ET
Bio-Rad Laboratories Enhances Financial Flexibility with New Credit Facility
Jan 26
8:45pm ET
RBC Capital Remains a Buy on Bio-Rad Laboratories (BIO)
Jan 26
9:55am ET
Early notable gainers among liquid option names on January 26th
Jan 17
12:28am ET
SPY ETF Update, 1/17/2024
Jan 15
7:13am ET
SPY ETF Update, 1/15/2024
No recent press releases are available for BIO
BIO Financials
Key terms
Ad Feedback
BIO Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
BIO Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
